Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

KTWO Insider Trading

KTWO | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at KTWO provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Last 7 Days
$0
Buys
$0
Sells
Last 30 Days Trend
$0
Buys
$0
Sells

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2026-02-14 05:47 2026-01-30 Thakur Karan Director, Officer, 10% owner - Chief Executive Officer BUY $0.00 326,875 $0 326,875 +100.0%
2026-02-14 05:46 2026-01-30 K2 CAPITAL SPONSOR LLC 10% owner BUY $0.00 326,875 $0 326,875 +100.0%
2018-09-05 00:39 2018-08-30 Cole Gregory S Officer - Chief Financial Officer OPT+S $27.40 82,304 $2,255,492 65,659 0.0%
2018-08-18 01:49 2018-08-16 Cole Gregory S Officer - Chief Financial Officer SELL $20.08 1,480 $29,715 65,659 -2.2%
2018-08-18 01:49 2018-08-16 MORATIS GEORGE Z Officer - Global Accounting Officer SELL $20.19 695 $14,035 22,655 -3.0%
2018-07-06 23:54 2018-07-03 Cole Gregory S Officer - Chief Financial Officer SELL $22.47 867 $19,482 67,139 -1.3%
2018-06-09 01:55 2018-06-08 MORATIS GEORGE Z Officer - Global Accounting Officer SELL $22.81 455 $10,378 20,699 -2.2%
2017-08-25 02:36 2017-08-23 KOSTUIK JOHN PHILIP MD Director, Officer - Chief Medical Officer SELL $23.30 1,332 $31,036 200,629 -0.7%
2017-08-17 01:21 2017-08-15 MORATIS GEORGE Z Officer - Global Accounting Officer SELL $24.09 770 $18,549 16,478 -4.5%
2017-08-17 01:21 2017-08-15 Cole Gregory S Officer - Chief Financial Officer SELL $24.08 2,350 $56,588 55,158 -4.1%
2017-08-17 01:21 2017-08-15 KOSTUIK JOHN PHILIP MD Director, Officer - Chief Medical Officer SELL $24.08 1,090 $26,247 201,961 -0.5%
2017-08-16 00:25 2017-08-11 Cole Gregory S Officer - Chief Financial Officer OPT+S $23.37 39,357 $919,631 57,508 0.0%
2017-07-06 03:18 2017-07-01 Cole Gregory S Officer - Chief Financial Officer SELL $24.33 956 $23,259 57,505 -1.6%
2017-06-17 00:42 2017-06-15 Cole Gregory S Officer - Chief Financial Officer OPT+S $22.80 42,947 $979,101 58,265 0.0%
2017-05-30 23:15 2017-05-25 KOSTUIK JOHN PHILIP MD Director, Officer - Chief Medical Officer SELL $22.70 50,000 $1,135,000 199,107 -20.1%
2017-05-16 00:40 2017-05-12 MORATIS GEORGE Z Officer - Global Accounting Officer SELL $21.77 1,000 $21,773 12,524 -7.4%
2017-05-11 00:54 2017-05-10 MORATIS GEORGE Z Officer - Global Accounting Officer OPT+S $21.61 902 $19,492 13,524 0.0%
2017-02-15 05:17 2017-01-26 Welsh, Carson, Anderson & Stowe XI, L.P. 10% owner SELL $20.23 3,926,068 $79,424,356 5,384,858 -42.2%
2017-02-15 05:12 2017-01-26 WCAS MANAGEMENT CORP 10% owner SELL $20.23 3,214 $65,019 4,409 -42.2%
2017-02-15 05:05 2017-01-26 WCAS Capital Partners IV, L.P. 10% owner SELL $20.23 57,488 $1,162,982 78,849 -42.2%
2017-01-25 00:43 2017-01-20 KOSTUIK JOHN PHILIP MD Director, Officer - Chief Medical Officer OPT+S $21.61 28,526 $616,550 249,107 0.0%
2017-01-20 02:38 2017-01-17 KOSTUIK JOHN PHILIP MD Director, Officer - Chief Medical Officer OPT+S $21.58 72,298 $1,560,263 249,107 0.0%
2016-11-18 21:27 2016-11-16 WCAS Capital Partners IV, L.P. 10% owner SELL $18.39 64,674 $1,189,355 136,337 -32.2%
2016-11-18 21:12 2016-11-16 Welsh, Carson, Anderson & Stowe XI, L.P. 10% owner SELL $18.39 4,416,825 $81,225,412 9,310,926 -32.2%
2016-11-18 20:56 2016-11-16 WCAS MANAGEMENT CORP 10% owner SELL $18.39 3,616 $66,498 7,623 -32.2%
2016-07-07 00:13 2016-07-01 Cole Gregory S Officer - Chief Financial Officer SELL $15.70 943 $14,807 40,808 -2.3%
2016-05-25 01:25 2016-05-21 Cole Gregory S Officer - Chief Financial Officer OPT+S $11.32 6,465 $73,184 26,768 0.0%
2016-05-10 23:49 2016-05-07 Cole Gregory S Officer - Chief Financial Officer OPT+S $11.45 1,702 $19,488 12,657 0.0%
2016-05-10 23:45 2016-05-07 MORATIS GEORGE Z Officer - Global Accounting Officer OPT+S $11.40 900 $10,260 4,183 0.0%
2016-05-06 02:03 2016-05-05 FERRER CARLOS A Director BUY $11.32 20,000 $226,400 59,382 +50.8%
2016-03-07 23:34 2016-03-07 FERRER CARLOS A Director BUY $12.84 38,942 $500,015 39,382 +8,850.5%
2015-11-14 00:43 2015-11-11 Cole Gregory S Officer - Chief Financial Officer OPT+S $19.70 41,574 $819,004 9,087 0.0%
2015-08-12 01:04 2015-08-07 Cole Gregory S Officer - Chief Financial Officer OPT+S $21.01 41,574 $873,561 9,087 0.0%
2015-07-22 00:36 2015-07-17 FERRER CARLOS A Director SELL $22.37 86,407 $1,932,925 57,796 -59.9%
2015-07-18 00:00 2015-07-17 WCAS Capital Partners IV, L.P. 10% owner SELL $22.60 6,842 $154,629 201,011 -3.3%
2015-07-17 23:47 2015-07-17 Welsh, Carson, Anderson & Stowe XI, L.P. 10% owner SELL $22.60 467,293 $10,560,822 13,727,751 -3.3%
2015-07-17 23:29 2015-07-17 WCAS MANAGEMENT CORP 10% owner SELL $22.60 383 $8,656 11,239 -3.3%
2015-07-16 00:47 2015-07-13 FERRER CARLOS A Director SELL $22.37 576,048 $12,886,194 60,838 -90.4%
2015-07-14 03:10 2015-07-13 WCAS MANAGEMENT CORP 10% owner SELL $22.60 2,551 $57,653 11,622 -18.0%
2015-07-14 03:03 2015-07-13 Welsh, Carson, Anderson & Stowe XI, L.P. 10% owner SELL $22.60 3,115,287 $70,405,486 14,195,044 -18.0%
2015-07-14 02:53 2015-07-13 WCAS Capital Partners IV, L.P. 10% owner SELL $22.60 45,616 $1,030,922 207,853 -18.0%
2015-06-30 03:19 2015-06-25 Cole Gregory S Officer - Chief Financial Officer OPT+S $24.22 38,989 $944,493 308 0.0%
2015-06-25 00:53 2015-06-22 Cole Gregory S Officer - Chief Financial Officer OPT+S $24.86 27,384 $680,881 308 0.0%
2015-06-25 00:51 2015-06-22 KOSTUIK JOHN PHILIP MD Director, Officer - Chief Medical Officer OPT+S $24.86 24,337 $605,132 237,071 0.0%
2015-06-24 04:44 2015-06-19 KOSTUIK JOHN PHILIP MD Director, Officer - Chief Medical Officer OPT+S $24.94 18,165 $453,035 237,071 0.0%
2015-06-24 04:43 2015-06-16 KOSTUIK JOHN PHILIP MD Director, Officer - Chief Medical Officer OPT+S $24.56 46,957 $1,153,424 237,071 0.0%
2015-06-19 02:26 2015-06-16 KOSTUIK JOHN PHILIP MD Director, Officer - Chief Medical Officer SELL $24.56 46,957 $1,153,424 190,114 -19.8%
2015-06-06 00:43 2015-06-03 Cole Gregory S Officer - Chief Financial Officer SELL $24.57 13,350 $328,010 308 -97.7%
2015-02-13 22:54 2015-02-12 BRODNAX BRETT Director SELL $19.73 5,564 $109,778 27,003 -17.1%
2015-02-11 03:18 2015-02-06 Welsh, Carson, Anderson & Stowe XI, L.P. 10% owner SELL $18.75 4,569,054 $85,669,763 17,310,331 -20.9%
SHOW ENTRIES
1-50 OF 56

How to Interpret $KTWO Trades

Not every insider transaction in KTWO is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $KTWO shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for KTWO

Insider activity data for KTWO is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $KTWO, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.